Clinical Trial

Treatment of Facial Flushing With Botulinum Toxin A Injections

Active, Not Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The purpose of this study is to find out if botulinum toxin A (botox®) can be used to treat facial flushing. This study is a pilot study designed to determine feasibility of these procedures.
Protocol Amendment History 15 amendments
This ClinicalTrials.gov record has been amended 15 times since 2014-08-12; most recent amendment 2026-06-29.
Status change: Recruiting → Active, Not Recruiting 2017-02-07
Trial Details
NCT Number NCT02216838
Lead Sponsor Northwestern University
Conditions Facial Flushing
Enrollment 16 participants
Start Date 2014-08
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-01